Posts Tagged: COVID-19
Senator Tillis Letter to Ambassador Tai: TRIPS Waiver (Copyright)
Dear Ambassador Tai: I write you again today for the fourth time about the Biden Administration’s waiver of international obligations under the Trade-Related Aspects of Intellectual …
Let No Good Deed Go Unpunished—The Tale of a COVID-19 Breakthrough
The lead story in last weekend’s Wall Street Journal made an exciting announcement: “Merck Covid-19 Pill Cuts Risks of Hospitalizations and Death”: "Merck & Co. and its …
U.S. Embassy Failures, COVID-19 Travel Restrictions, Keep Attorney Working on COVID-19 Technology Out of United States
Surely there can be no greater national interest to the United States than to allow each and every single person working to solve the COVID-19 pandemic to …
Iancu, Kilbride, Israel Separate Fact from Fiction During IPWatchdog LIVE Panel on TRIPS IP Waiver
On Monday of IPWatchdog LIVE in Dallas, a panel on “The TRIPS IP Waiver: Separating Fact & Fiction" was moderated by president and CEO of the PCT learning …
The Innovation Ecosystem Behind COVID Vaccines is Now Targeting HIV/AIDS
June marked the 40th anniversary of the first reported AIDS case. On the anniversary, UNAIDS released a strategy to end HIV/AIDS by 2030, a goal that seemed …
Bankrupting Big Pharma Isn’t a Solution
Believe it or not, a recent op-ed in the Washington Post written by Robin Feldman took the position that pharmaceutical companies should charge prices for their drugs …
What is a ‘Patent Waiver’ Anyway? Zooming Out on the TRIPS COVID IP Waiver Debate
Scientists, engineers, and everyday people have developed solutions for testing, preventing, and treating the COVID-19 disease. Ordinarily, we wouldn’t think twice about granting patents on these …
A Third Option: Limited IP Waiver Could Solve Our Pandemic Vaccine Problems
In the early days of the vaccination efforts, Americans were anxiously online trying to register for a COVID-19 vaccination appointment. Reports of success at 1:30 am and 2:30 am …
Emerging Anti-IP Policies the Focus of Heritage Foundation Event
At today’s Heritage Foundation event in Washington, D.C., titled Restoring American Leadership in Patent Law and Innovation Policy, former U.S. Patent and Trademark Office …
International Academics Push for TRIPS COVID IP Waiver Hold-Outs to Drop Opposition
One-hundred-twenty-four professors and academics from around the world have penned an open letter supporting India and South Africa’s proposed waiver of certain provisions of the Agreement …
Extending the Innovation Pipeline to Africa’s Patients
With summer underway in the United States, we want to believe the global pandemic is ending. In many cities, restaurants are at near-full capacity, scaled-back festivals are …
Game On: How IP Helps the Video Game Industry Level Up
While countless industries have been forced to adapt to the COVID-19 pandemic, the video game industry has been on a winning streak. Historic numbers of people have …
Waiving IP Rights: The Wrong Path to the Right Goals
Waiving intellectual property (IP) protections for COVID-19 vaccines will hinder rather than further three meritorious objectives of the current U.S. Presidential Administration: ending the pandemic as …
Vaccines, Intellectual Property, and Global Equity
The rollout of effective COVID-19 vaccines is happening at a historically unprecedented pace. Manufacturing and delivering vaccines to some 7.8 billion people worldwide, however, has reignited tensions about …
EU Offers Alternative to COVID-19 IP Waiver That Supports Innovation and Addresses Supply Chain Problems
On June 4, the European Commission submitted to the World Trade Organization (WTO) its proposal for improving access to COVID-19 vaccines and treatments in countries suffering from vaccine …
